Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF
Groundbreaking Drug for Treating 2 Rare Forms of Epilepsy Now Available – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
A ground-breaking cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is now available by prescription in the United States to treat seizures associated with Dravet syndrome or Lennox-Gastaut syndrome (LGS) in patients aged 2 years or older.1
Approved by the FDA in June, Epidiolex is the first prescription pharmaceutical formulation of highly purified, plant-derived cannabidiol (CBD), a cannabinoid lacking the high associated with marijuana, and the first in a new category of anti-epileptic drugs.1,2
Epidiolex provides a new treatment option for patients with 2 of the most difficult-to-treat forms of childhood-onset epilepsy, according to Justin Gover, chief executive officer of GW Pharmaceuticals.1
